Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
Abstract Artemisinin resistance has emerged and spread in the Greater Mekong Sub-region (GMS), followed by artemisinin-based combination therapy failure, due to both artemisinin and partner drug resistance. More worrying, artemisinin resistance has been recently reported and confirmed in Rwanda. The...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-10-01
|
| Series: | Malaria Journal |
| Online Access: | https://doi.org/10.1186/s12936-021-03942-5 |